Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% |
|
-.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Clinic Testing
92.6
%
| 1 | 20.5 % | 22 | 92.6 % | +4,049.80% |
Cannaboid Products
3.8
%
| 2 | 64.5 % | 1 | 3.8 % | -45.40% |
Wholesale
2.4
%
| 0 | 2.2 % | 1 | 2.4 % | +883.77% |
Cannaboid Testing
1.2
%
| 0 | 12.8 % | 0 | 1.2 % | -16.19% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 3 | 100.0 % | 23 | 100.0 % | +817.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Emily Critchley
HRO | Human Resources Officer | - | - |
Paul van Issum
PRN | Corporate Officer/Principal | - | - |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 364,962,760 | 256,430,105 ( 70.26 %) | 0 | 70.26 % |
Company contact information
![address Goodbody Health Limited(GDBYF)](https://cdn.zonebourse.com/static/address/119074727.png)
Group companies
Name | Category and Sector |
---|---|
Sativa Group Plc
![]() Sativa Group Plc Financial ConglomeratesFinance Sativa Group Plc engages in the production, testing and compliance, commercialization, sales, and marketing of cannabidiol products. It operates through the following segments: Products; Testing; and Extraction and Research and Development. The Products segment focuses in the sale of cannabidiol products. The Testing segment involves in testing cannabidiol products. The Extraction and Research and Development segment include extraction and research and development operations which develops future products. The company was founded by Geremy Howard Prance Thomas on December 19, 2017 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Sector
Sales per Business
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 36 | |
+7.30% | 4.81B | |
-31.08% | 3.6B | |
-0.71% | 3.09B | |
-24.32% | 2.62B | |
-11.35% | 2.27B | |
+34.19% | 1.82B | |
+33.49% | 1.41B | |
-15.07% | 1.38B | |
+40.95% | 1.37B |
- Stock Market
- Equities
- GDBYF Stock
- Company Goodbody Health Limited